BIOMAT Database Logo BIOMAT Database Logo

(E)-4-(2-[[3-(indol-5-yl)-1-oxo-2-butenyl]amino]phenoxy)butyric acid derivatives: a new class of steroid 5 alpha-reductase inhibitors in the rat prostate. 1. 1995

T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.

A series of (E)-4-(2-[[3-(indol-5-yl)-1-oxo-2-butenyl]amino]phenoxy)butyric acid derivatives was prepared, and the derivatives were demonstrated to be potent inhibitors of steroid 5 alpha-reductase in the rat prostate. The structure-activity relationships were as follows. An alpha-branched alkyl or benzyl substituent of proper size at position 1 of the indole is crucial for optimal enzyme inhibitory activity. N-Methylation of the amide NH resulted in complete loss of activity. Thus, coplanarity of the benzene ring and amide moiety is essential for such activity. Among the compounds prepared, (E)-4-(2-[[3-[1-[bis(4-fluorophenyl)methyl]indol-5-yl]-1-oxo-2- butenyl]-amino]phenoxy)butyric acid (57, KF18678) was one of the most potent compounds (rat prostate 5 alpha-reductase IC50 = 3.3 nM).

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D002087 Butyrates Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure. Butyrate,n-Butyrate,Butanoic Acids,Butyric Acids,Acids, Butanoic,Acids, Butyric,n Butyrate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
Pyrrole butyric acid derivatives as inhibitors of steroid 5 alpha-reductase.
November 1997, Chemical & pharmaceutical bulletin,
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
4-(1-benzoylindol-3-yl)butyric acids and FK143: novel nonsteroidal inhibitors of steroid 5 alpha-reductase (II).
April 1999, Chemical & pharmaceutical bulletin,
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
Tissue distribution kinetics of a new nonsteroidal 5 alpha-reductase [correction of 5 A-reductase] inhibitor, 4-[3-[3-[bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-YL ]-butyric acid, in rats.
September 1997, Drug metabolism and disposition: the biological fate of chemicals,
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
(5-Hydroxy-4-oxo-2-styryl-4H-pyridin-1-yl)-acetic Acid Derivatives as Multifunctional Aldose Reductase Inhibitors.
November 2020, Molecules (Basel, Switzerland),
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
3-Amino-5-(indol-3-yl)methylene-4-oxo-2-thioxothiazolidine Derivatives as Antimicrobial Agents: Synthesis, Computational and Biological Evaluation.
September 2020, Pharmaceuticals (Basel, Switzerland),
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
August 1996, Journal of medicinal chemistry,
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
1-Benzyl-2-(1H-indol-3-yl)-5-oxo-pyrrolidine-2-carbonitrile.
January 2008, Acta crystallographica. Section E, Structure reports online,
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
Discovery of 3-(4-(2-((1H-Indol-5-yl)amino)-5-fluoropyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel Disease.
February 2021, Journal of medicinal chemistry,
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
[Derivatives of 5-(2-amino-4-oxo-6-methyl-3,4-dihydropyrimidine-5-yl)pentanoic acid].
March 1987, Ceskoslovenska farmacie,
T Kumazawa, and H Takami, and N Kishibayashi, and A Ishii, and Y Nagahara, and N Hirayama, and H Obase
A novel class of inhibitors for human steroid 5 alpha-reductase: phenoxybenzoic acid derivatives. I.
August 1999, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!